Bloom Remedies (India) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 14 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 19.07%
- Profit Growth 258.46%
- Ebitda 584.81%
- Net Worth 17.04%
- Total Assets -4.75%
About Bloom Remedies (India)
Bloom Remedies (India) Limited (BRIL) is a Public Limited Indian Non-Government Company incorporated in India on 23 December 2010 and has a history of 14 years and one month. Its registered office is in Coimbatore, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Thulasalamdom Narayanan, Parthasarathy Muralivijayan, Subramaniam Radhakrishnan, and Four other members serve as directors at the Company.
Company Details
-
Location
Coimbatore, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85100TZ2010PLC016620
-
Company No.
016620
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
23 Dec 2010
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Coimbatore
Industry
Who are the key members and board of directors at Bloom Remedies (India)?
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Thulasalamdom Narayanan
|
Director | 23-Dec-2010 | Current |
|
Parthasarathy Muralivijayan
|
Director | 23-Dec-2010 | Current |
|
Subramaniam Radhakrishnan
|
Director | 23-Dec-2010 | Current |
|
Subramaniam Balakumar
|
Director | 23-Dec-2010 | Current |
|
Chidambaram Duraimurugan
|
Director | 23-Dec-2010 | Current |
|
Thangavelu Venkatesh
|
Director | 23-Dec-2010 | Current |
Financial Performance of Bloom Remedies (India).
Bloom Remedies (India) Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 19.07% increase. The company also saw a substantial improvement in profitability, with a 258.46% increase in profit. The company's net worth Soared by an impressive increase of 17.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bloom Remedies (India)?
In 2020, Bloom Remedies (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Bdn Technologies Private LimitedSubramaniam Balakumar and Chidambaram Duraimurugan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bloom Remedies (India)?
Unlock and access historical data on people associated with Bloom Remedies (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bloom Remedies (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bloom Remedies (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.